Management of Depression in Patients with Comorbid Cardiovascular Disease.
- Published in:
- Journal of Pharmacy Practice, 2001, v. 14, n. 6, p. 526, doi. 10.1177/089719001129040874
- By:
- Publication type:
- Article
Works by Nelson, Leigh Anne
Results: 21
1
2
Factors associated with COVID-19 vaccination for patients in an inpatient forensic psychiatric hospital.
- Published in:
- International Journal of Psychiatry in Medicine, 2023, v. 58, n. 2, p. 160, doi. 10.1177/00912174221144128
- By:
- Publication type:
- Article
3
Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit.
- Published in:
- Psychopharmacology Bulletin, 2019, v. 49, n. 2, p. 8
- By:
- Publication type:
- Article
4
Guidance on the treatment of antipsychotic-induced hyperprolactinemia when switching the antipsychotic is not an option.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 10, p. 862, doi. 10.1093/ajhp/zxab065
- By:
- Publication type:
- Article
5
Cost-avoidance and qualitative analysis of clinical pharmacy interventions by psychiatric pharmacy residents at state psychiatric facilities.
- Published in:
- American Journal of Health-System Pharmacy, 2016, v. 73, n. 1, p. e46, doi. 10.2146/ajhp150368
- By:
- Publication type:
- Article
6
Effectiveness Evaluation of a Pharmacist-Driven Monitoring Database for Tardive Dyskinesia.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
7
Adverse Drug Reactions: A Retrospective Review of Hospitalized Patients at a State Psychiatric Hospital.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
8
Characterization of Medication Discrepancies Occurring at the Time of Discharge From an Adult State Psychiatric Inpatient Facility.
- Published in:
- Hospital Pharmacy, 2011, v. 46, n. 4, p. 254, doi. 10.1310/hpj4604-254
- By:
- Publication type:
- Article
9
A Pharmacokinetic Drug-Drug Interaction Study of Venlafaxine and Indinavir.
- Published in:
- Psychopharmacology Bulletin, 2001, v. 35, n. 2, p. 62
- By:
- Publication type:
- Article
10
Identification, Assessment, and Clinical Management of Tardive Dyskinesia: An Update.
- Published in:
- Psychiatric Times, 2019, v. 36, n. 7, p. 27
- By:
- Publication type:
- Article
11
Antipsychotic Cost-Effectiveness.
- Published in:
- Psychiatric Times, 2007, v. 24, p. 3
- By:
- Publication type:
- Article
12
Zuranolone: The First FDA-Approved Oral Treatment Option for Postpartum Depression.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 7, p. 728, doi. 10.1177/10600280231204953
- By:
- Publication type:
- Article
13
Dexmedetomidine Sublingual Film: A New Treatment to Reduce Agitation in Schizophrenia and Bipolar Disorders.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 1, p. 54, doi. 10.1177/10600280231171179
- By:
- Publication type:
- Article
14
Medication adherence and glycemic control in patients with psychotic disorders in the Veterans Affairs healthcare system.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
15
Medication adherence and glycemic control in patients with psychotic disorders in the Veterans Affairs healthcare system.
- Published in:
- Pharmacy Practice (1886-3655), 2011, v. 9, n. 2, p. 57, doi. 10.4321/S1886-36552011000200001
- By:
- Publication type:
- Article
16
Xylazine Adulteration in Illicit Fentanyl: A Threat to Public Health.
- Published in:
- Journal of Pharmacy Practice, 2025, v. 38, n. 2, p. 264, doi. 10.1177/08971900241279635
- By:
- Publication type:
- Article
17
Psychotropic-Induced Priapism in a Treatment-Refractory Patient: A Case Report.
- Published in:
- Journal of Pharmacy Practice, 2021, v. 32, n. 2, p. 309, doi. 10.1177/0897190019885233
- By:
- Publication type:
- Article
18
Enhancing Outcomes: Acceptability of Medication Formulations for the Treatment of Acute Agitation in a Psychiatric Population.
- Published in:
- Pharmacy, 2023, v. 11, n. 1, p. 4, doi. 10.3390/pharmacy11010004
- By:
- Publication type:
- Article
19
Olanzapine/Samidorphan: A New Combination Treatment for Schizophrenia and Bipolar I Disorder Intended to Reduce Weight Gain.
- Published in:
- CNS Drugs, 2022, v. 36, n. 6, p. 605, doi. 10.1007/s40263-022-00923-3
- By:
- Publication type:
- Article
20
Managing psychotropic-induced hyperhidrosis.
- Published in:
- Current Psychiatry, 2023, v. 22, n. 11, p. 33, doi. 10.12788/cp.0399
- By:
- Publication type:
- Article
21
Historical Review of Carbamazepine for the Treatment of Bipolar Disorder.
- Published in:
- Pharmacotherapy, 2007, v. 27, n. 1, p. 68, doi. 10.1592/phco.27.1.68
- By:
- Publication type:
- Article